Scholars@Duke publication: Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure.

Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure.

Publication , Journal Article

Steinberg, BA; Mentz, RJ

Published in: JACC Heart Fail

March 2017

Published version (DOI) Link to item

Duke Scholars

Author Robert John Mentz Medicine, Cardiology

Published In

JACC Heart Fail

DOI

10.1016/j.jchf.2017.01.004

EISSN

2213-1787

Publication Date

March 2017

Volume

Issue

Start / End Page

213 / 215

Location

United States

Related Subject Headings

Treatment Outcome
Humans
Heart Failure
Defibrillators, Implantable
Cost-Benefit Analysis
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy
3201 Cardiovascular medicine and haematology
1102 Cardiorespiratory Medicine and Haematology

Citation

APA

Chicago

ICMJE

MLA

NLM

Steinberg, B. A., & Mentz, R. J. (2017). Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure. JACC Heart Fail, 5(3), 213–215. https://doi.org/10.1016/j.jchf.2017.01.004

Steinberg, Benjamin A., and Robert J. Mentz. “Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure.” JACC Heart Fail 5, no. 3 (March 2017): 213–15. https://doi.org/10.1016/j.jchf.2017.01.004.

Steinberg BA, Mentz RJ. Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure. JACC Heart Fail. 2017 Mar;5(3):213–5.

Steinberg, Benjamin A., and Robert J. Mentz. “Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure.” JACC Heart Fail, vol. 5, no. 3, Mar. 2017, pp. 213–15. Pubmed, doi:10.1016/j.jchf.2017.01.004.

Steinberg BA, Mentz RJ. Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure. JACC Heart Fail. 2017 Mar;5(3):213–215.

Published In

JACC Heart Fail

DOI

10.1016/j.jchf.2017.01.004

EISSN

2213-1787

Publication Date

March 2017

Volume

Issue

Start / End Page

213 / 215

Location

United States

Related Subject Headings

Treatment Outcome
Humans
Heart Failure
Defibrillators, Implantable
Cost-Benefit Analysis
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy
3201 Cardiovascular medicine and haematology
1102 Cardiorespiratory Medicine and Haematology